Photodynamic therapy for atherosclerosis. The potential of indocyanine green
•Prevention and treatment of restenosis in cardiovascular disease is an important problem.•Cardiovascular applications of photodynamic therapy are evaluated.•The ideal photosensitizer for photodynamic therapy in atherosclerosis is an unresolved question.•The role of indocyanine green as a photosensi...
Gespeichert in:
| Veröffentlicht in: | Photodiagnosis and photodynamic therapy 2020-03, Vol.29, p.101568, Article 101568 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 101568 |
| container_title | Photodiagnosis and photodynamic therapy |
| container_volume | 29 |
| creator | Houthoofd, S. Vuylsteke, M. Mordon, S. Fourneau, I. |
| description | •Prevention and treatment of restenosis in cardiovascular disease is an important problem.•Cardiovascular applications of photodynamic therapy are evaluated.•The ideal photosensitizer for photodynamic therapy in atherosclerosis is an unresolved question.•The role of indocyanine green as a photosensitizer in photodynamic therapy for atherosclerosis deserves further research.
The aim of this article is to summarize and review the use of photodynamic therapy for the treatment of atherosclerotic plaque and the prevention of intimal hyperplasia. Different photosensitizers are discussed and more specifically the role of indocyanine green as a potential photosensitizer.
Literature search with focus on the use of photodynamic therapy in atherosclerosis, the mechanism of action and the different photosensitizers for photodynamic therapy.
In-vitro and in-vivo studies confirm the possibilities of using photodynamic therapy for the treatment of atherosclerosis and the prevention of restenosis. Insufficient specificity in the accumulation of photosensitizer and thus phototoxicity, remains an important problem. Indocyanine green is a photosensitizer with features in favor of photodynamic therapy. Results obtained so far of photodynamic therapy with indocyanine green point towards the potential of indocyanine green as a photosensitizer in photodynamic therapy for atherosclerosis.
Photodynamic therapy is a promising tool for treating atherosclerosis. Many of the studied photosensitizers have toxic effects. Indocyanine green might be a good photosensitizer for the use of photodynamic therapy in atherosclerosis. These data justify further research to the use of indocyanine green as a photosensitizer in the treatment of atherosclerotic plaque both de novo or in restenotic lesions. |
| doi_str_mv | 10.1016/j.pdpdt.2019.10.003 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_webof</sourceid><recordid>TN_cdi_webofscience_primary_000527929400060CitationCount</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1572100018301261</els_id><sourcerecordid>31627015</sourcerecordid><originalsourceid>FETCH-LOGICAL-c404t-4836862714e5864c8100f5af11e02f440af18b43a544f28aae72d324c1d0e0e43</originalsourceid><addsrcrecordid>eNqNkEtPwzAQhC0EoqXwC5BQ7ihh7TivAwcU8ZIqwaGcI9deU1etHSUuKP8eh0KPiIs9Xs1nzQ4hlxQSCjS_WSetapVPGNAqTBKA9IhMaVmkMc2q4jjorGAxBYAJOev7dTDwCvgpmaQ0ZwXQbErmryvnnRqs2BoZ-RV2oh0i7bpIjA_Xy814mj6JFiuMWufReiM2kdORscrJQVhjMXrvEO05OdFi0-PFzz0jbw_3i_opnr88Ptd381hy4D7mZZqXIQDlmJU5l2WIqDOhKUVgmnMIslzyVGSca1YKgQVTKeOSKkBAns5Iuv9Xhmh9h7ppO7MV3dBQaMZumnXz3U0zdjMOw-qButpT7W65RXVgfssIhnJv-MSl0700aCUebKHGjBUVq3hQOdTGC2-crd3O-oBe_x8N7tu9G0NJHwa75odQpkPpG-XMn5t8Acmwlxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Photodynamic therapy for atherosclerosis. The potential of indocyanine green</title><source>MEDLINE</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>Access via ScienceDirect (Elsevier)</source><creator>Houthoofd, S. ; Vuylsteke, M. ; Mordon, S. ; Fourneau, I.</creator><creatorcontrib>Houthoofd, S. ; Vuylsteke, M. ; Mordon, S. ; Fourneau, I.</creatorcontrib><description>•Prevention and treatment of restenosis in cardiovascular disease is an important problem.•Cardiovascular applications of photodynamic therapy are evaluated.•The ideal photosensitizer for photodynamic therapy in atherosclerosis is an unresolved question.•The role of indocyanine green as a photosensitizer in photodynamic therapy for atherosclerosis deserves further research.
The aim of this article is to summarize and review the use of photodynamic therapy for the treatment of atherosclerotic plaque and the prevention of intimal hyperplasia. Different photosensitizers are discussed and more specifically the role of indocyanine green as a potential photosensitizer.
Literature search with focus on the use of photodynamic therapy in atherosclerosis, the mechanism of action and the different photosensitizers for photodynamic therapy.
In-vitro and in-vivo studies confirm the possibilities of using photodynamic therapy for the treatment of atherosclerosis and the prevention of restenosis. Insufficient specificity in the accumulation of photosensitizer and thus phototoxicity, remains an important problem. Indocyanine green is a photosensitizer with features in favor of photodynamic therapy. Results obtained so far of photodynamic therapy with indocyanine green point towards the potential of indocyanine green as a photosensitizer in photodynamic therapy for atherosclerosis.
Photodynamic therapy is a promising tool for treating atherosclerosis. Many of the studied photosensitizers have toxic effects. Indocyanine green might be a good photosensitizer for the use of photodynamic therapy in atherosclerosis. These data justify further research to the use of indocyanine green as a photosensitizer in the treatment of atherosclerotic plaque both de novo or in restenotic lesions.</description><identifier>ISSN: 1572-1000</identifier><identifier>EISSN: 1873-1597</identifier><identifier>DOI: 10.1016/j.pdpdt.2019.10.003</identifier><identifier>PMID: 31627015</identifier><language>eng</language><publisher>AMSTERDAM: Elsevier B.V</publisher><subject>Animals ; Apoptosis - drug effects ; Atherosclerosis ; Atherosclerosis - drug therapy ; Humans ; Indocyanine green ; Indocyanine Green - administration & dosage ; Indocyanine Green - therapeutic use ; Intimal hyperplasia ; Life Sciences & Biomedicine ; Oncology ; Photochemotherapy - methods ; Photodynamic therapy ; Photosensitizers ; Photosensitizing Agents - administration & dosage ; Photosensitizing Agents - therapeutic use ; Reactive Oxygen Species - metabolism ; Science & Technology</subject><ispartof>Photodiagnosis and photodynamic therapy, 2020-03, Vol.29, p.101568, Article 101568</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>52</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000527929400060</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c404t-4836862714e5864c8100f5af11e02f440af18b43a544f28aae72d324c1d0e0e43</citedby><cites>FETCH-LOGICAL-c404t-4836862714e5864c8100f5af11e02f440af18b43a544f28aae72d324c1d0e0e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pdpdt.2019.10.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3552,27931,27932,28255,46002</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31627015$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Houthoofd, S.</creatorcontrib><creatorcontrib>Vuylsteke, M.</creatorcontrib><creatorcontrib>Mordon, S.</creatorcontrib><creatorcontrib>Fourneau, I.</creatorcontrib><title>Photodynamic therapy for atherosclerosis. The potential of indocyanine green</title><title>Photodiagnosis and photodynamic therapy</title><addtitle>PHOTODIAGN PHOTODYN</addtitle><addtitle>Photodiagnosis Photodyn Ther</addtitle><description>•Prevention and treatment of restenosis in cardiovascular disease is an important problem.•Cardiovascular applications of photodynamic therapy are evaluated.•The ideal photosensitizer for photodynamic therapy in atherosclerosis is an unresolved question.•The role of indocyanine green as a photosensitizer in photodynamic therapy for atherosclerosis deserves further research.
The aim of this article is to summarize and review the use of photodynamic therapy for the treatment of atherosclerotic plaque and the prevention of intimal hyperplasia. Different photosensitizers are discussed and more specifically the role of indocyanine green as a potential photosensitizer.
Literature search with focus on the use of photodynamic therapy in atherosclerosis, the mechanism of action and the different photosensitizers for photodynamic therapy.
In-vitro and in-vivo studies confirm the possibilities of using photodynamic therapy for the treatment of atherosclerosis and the prevention of restenosis. Insufficient specificity in the accumulation of photosensitizer and thus phototoxicity, remains an important problem. Indocyanine green is a photosensitizer with features in favor of photodynamic therapy. Results obtained so far of photodynamic therapy with indocyanine green point towards the potential of indocyanine green as a photosensitizer in photodynamic therapy for atherosclerosis.
Photodynamic therapy is a promising tool for treating atherosclerosis. Many of the studied photosensitizers have toxic effects. Indocyanine green might be a good photosensitizer for the use of photodynamic therapy in atherosclerosis. These data justify further research to the use of indocyanine green as a photosensitizer in the treatment of atherosclerotic plaque both de novo or in restenotic lesions.</description><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Atherosclerosis</subject><subject>Atherosclerosis - drug therapy</subject><subject>Humans</subject><subject>Indocyanine green</subject><subject>Indocyanine Green - administration & dosage</subject><subject>Indocyanine Green - therapeutic use</subject><subject>Intimal hyperplasia</subject><subject>Life Sciences & Biomedicine</subject><subject>Oncology</subject><subject>Photochemotherapy - methods</subject><subject>Photodynamic therapy</subject><subject>Photosensitizers</subject><subject>Photosensitizing Agents - administration & dosage</subject><subject>Photosensitizing Agents - therapeutic use</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Science & Technology</subject><issn>1572-1000</issn><issn>1873-1597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><recordid>eNqNkEtPwzAQhC0EoqXwC5BQ7ihh7TivAwcU8ZIqwaGcI9deU1etHSUuKP8eh0KPiIs9Xs1nzQ4hlxQSCjS_WSetapVPGNAqTBKA9IhMaVmkMc2q4jjorGAxBYAJOev7dTDwCvgpmaQ0ZwXQbErmryvnnRqs2BoZ-RV2oh0i7bpIjA_Xy814mj6JFiuMWufReiM2kdORscrJQVhjMXrvEO05OdFi0-PFzz0jbw_3i_opnr88Ptd381hy4D7mZZqXIQDlmJU5l2WIqDOhKUVgmnMIslzyVGSca1YKgQVTKeOSKkBAns5Iuv9Xhmh9h7ppO7MV3dBQaMZumnXz3U0zdjMOw-qButpT7W65RXVgfssIhnJv-MSl0700aCUebKHGjBUVq3hQOdTGC2-crd3O-oBe_x8N7tu9G0NJHwa75odQpkPpG-XMn5t8Acmwlxg</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Houthoofd, S.</creator><creator>Vuylsteke, M.</creator><creator>Mordon, S.</creator><creator>Fourneau, I.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202003</creationdate><title>Photodynamic therapy for atherosclerosis. The potential of indocyanine green</title><author>Houthoofd, S. ; Vuylsteke, M. ; Mordon, S. ; Fourneau, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c404t-4836862714e5864c8100f5af11e02f440af18b43a544f28aae72d324c1d0e0e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Atherosclerosis</topic><topic>Atherosclerosis - drug therapy</topic><topic>Humans</topic><topic>Indocyanine green</topic><topic>Indocyanine Green - administration & dosage</topic><topic>Indocyanine Green - therapeutic use</topic><topic>Intimal hyperplasia</topic><topic>Life Sciences & Biomedicine</topic><topic>Oncology</topic><topic>Photochemotherapy - methods</topic><topic>Photodynamic therapy</topic><topic>Photosensitizers</topic><topic>Photosensitizing Agents - administration & dosage</topic><topic>Photosensitizing Agents - therapeutic use</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Science & Technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Houthoofd, S.</creatorcontrib><creatorcontrib>Vuylsteke, M.</creatorcontrib><creatorcontrib>Mordon, S.</creatorcontrib><creatorcontrib>Fourneau, I.</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Photodiagnosis and photodynamic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Houthoofd, S.</au><au>Vuylsteke, M.</au><au>Mordon, S.</au><au>Fourneau, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Photodynamic therapy for atherosclerosis. The potential of indocyanine green</atitle><jtitle>Photodiagnosis and photodynamic therapy</jtitle><stitle>PHOTODIAGN PHOTODYN</stitle><addtitle>Photodiagnosis Photodyn Ther</addtitle><date>2020-03</date><risdate>2020</risdate><volume>29</volume><spage>101568</spage><pages>101568-</pages><artnum>101568</artnum><issn>1572-1000</issn><eissn>1873-1597</eissn><abstract>•Prevention and treatment of restenosis in cardiovascular disease is an important problem.•Cardiovascular applications of photodynamic therapy are evaluated.•The ideal photosensitizer for photodynamic therapy in atherosclerosis is an unresolved question.•The role of indocyanine green as a photosensitizer in photodynamic therapy for atherosclerosis deserves further research.
The aim of this article is to summarize and review the use of photodynamic therapy for the treatment of atherosclerotic plaque and the prevention of intimal hyperplasia. Different photosensitizers are discussed and more specifically the role of indocyanine green as a potential photosensitizer.
Literature search with focus on the use of photodynamic therapy in atherosclerosis, the mechanism of action and the different photosensitizers for photodynamic therapy.
In-vitro and in-vivo studies confirm the possibilities of using photodynamic therapy for the treatment of atherosclerosis and the prevention of restenosis. Insufficient specificity in the accumulation of photosensitizer and thus phototoxicity, remains an important problem. Indocyanine green is a photosensitizer with features in favor of photodynamic therapy. Results obtained so far of photodynamic therapy with indocyanine green point towards the potential of indocyanine green as a photosensitizer in photodynamic therapy for atherosclerosis.
Photodynamic therapy is a promising tool for treating atherosclerosis. Many of the studied photosensitizers have toxic effects. Indocyanine green might be a good photosensitizer for the use of photodynamic therapy in atherosclerosis. These data justify further research to the use of indocyanine green as a photosensitizer in the treatment of atherosclerotic plaque both de novo or in restenotic lesions.</abstract><cop>AMSTERDAM</cop><pub>Elsevier B.V</pub><pmid>31627015</pmid><doi>10.1016/j.pdpdt.2019.10.003</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1572-1000 |
| ispartof | Photodiagnosis and photodynamic therapy, 2020-03, Vol.29, p.101568, Article 101568 |
| issn | 1572-1000 1873-1597 |
| language | eng |
| recordid | cdi_webofscience_primary_000527929400060CitationCount |
| source | MEDLINE; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; Access via ScienceDirect (Elsevier) |
| subjects | Animals Apoptosis - drug effects Atherosclerosis Atherosclerosis - drug therapy Humans Indocyanine green Indocyanine Green - administration & dosage Indocyanine Green - therapeutic use Intimal hyperplasia Life Sciences & Biomedicine Oncology Photochemotherapy - methods Photodynamic therapy Photosensitizers Photosensitizing Agents - administration & dosage Photosensitizing Agents - therapeutic use Reactive Oxygen Species - metabolism Science & Technology |
| title | Photodynamic therapy for atherosclerosis. The potential of indocyanine green |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-08T01%3A08%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Photodynamic%20therapy%20for%20atherosclerosis.%20The%20potential%20of%20indocyanine%20green&rft.jtitle=Photodiagnosis%20and%20photodynamic%20therapy&rft.au=Houthoofd,%20S.&rft.date=2020-03&rft.volume=29&rft.spage=101568&rft.pages=101568-&rft.artnum=101568&rft.issn=1572-1000&rft.eissn=1873-1597&rft_id=info:doi/10.1016/j.pdpdt.2019.10.003&rft_dat=%3Cpubmed_webof%3E31627015%3C/pubmed_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31627015&rft_els_id=S1572100018301261&rfr_iscdi=true |